Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts
Carl Potter
-
- Principal & Managing Director, Birmingham
-
- Sales & Leasing
- Office Midlands


News and updates
-
News Release
Avison Young named real estate service provider on Fujitsu’s Northwest Europe frameworkJuly 4, 2022
-
News Release
Suffolk’s Ufford Park Hotel Golf & Spa changes hands after 30 yearsJune 30, 2022
-
News Release
Citrus secures £75m funding for Integra 61 DurhamJune 28, 2022
-
Avison Young announces senior leadership promotions to drive EMEA alignment and growthJune 27, 2022